Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/4241
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShyni, G L-
dc.contributor.authorRenjitha, J-
dc.contributor.authorSasidhar, B S-
dc.contributor.authorRaghu, K G-
dc.date.accessioned2023-01-31T09:04:46Z-
dc.date.available2023-01-31T09:04:46Z-
dc.date.issued2021-06-
dc.identifier.citationJournal of Biochemical and Molecular Toxicology;35(6):1-11en_US
dc.identifier.urihttps://doi.org/10.1002/jbt.22777-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/4241-
dc.description.abstractZerumin A (ZA) is one of the potential components of Curcuma amada rhizomes, and it has been shown to possess a variety of pharmacological activities. This study deals with the beneficial activity of ZA in lipopolysaccharide (LPS)-stimulated inflammation in H9c2 cardiomyoblasts. Herein, H9c2 cells were preincubated with ZA for 1 h and stimulated with LPS for 24 h. The cells were analyzed for the expression of various pro-inflammatory mediators and signaling molecules. Results showed that the cell viability was significantly improved and reactive oxygen species production was alleviated remarkably with ZA pretreatment. We also found that ZA pretreatment significantly suppressed the upregulation of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) protein levels, and nitric oxide (NO) release in LPS-stimulated cells. In addition, ZA significantly ameliorated LPS-elicited overexpression of pro-inflammatory chemokines and cytokines such as monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor α (TNF- α), interferon-γ (IFN-γ), and interleukin-1 (IL-1) in H9c2 cells, and it upregulated the synthesis of the anti-inflammatory cytokine interleukin-10 (IL-10). Moreover, pretreatment with ZA and the mitogen-activated protein kinases (MAPK) pathway inhibitors also reduced the phosphorylation of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinases (JNK), and p38. ZA significantly inhibited IkB-a phosphorylation and nuclear factor (NF)-kB p65 subunit translocation into nuclei. Overall data demonstrated that ZA protects cardiomyocytes against LPS injury by inhibiting NF-kB p65 activation via the MAPK signaling pathway in vitro. These findings suggest that ZA may be a promising agent for a detailed study for the prevention or treatment of myocardial dysfunction in sepsis.en_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.subjectcytokinesen_US
dc.subjectH9c2 cellsen_US
dc.subjectinducible nitric oxide synthaseen_US
dc.subjectlipopolysaccharideen_US
dc.subjectZerumin Aen_US
dc.titleZerumin a Attenuates the Inflammatory Responses in LPS‐stimulated H9c2 Cardiomyoblastsen_US
dc.typeArticleen_US
Appears in Collections:2021

Files in This Item:
File Description SizeFormat 
Zerumin A attenuates the inflammatory responses in LPS‐stimulated H9c2_Shyni _J Biochem Molecular Tox.pdf
  Restricted Access
3.17 MBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.